New antiviral agents

Nahed Abdel-Haq, Pimpanada Chearskul, Hossam Al-Tatari, Basim Asmar

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


During the last three decades, a better understanding of viral replication and disease states caused by viral infections have led to the development of newer antiviral agents with enhanced activity and better tolerability. This review focuses on newer systemic and topical antiviral agents that are used in treatment of herpes viruses including herpes simplex type-1 (HSV-1) and type-2 (HSV-2), varicella-zoster virus (VZV) and cytomegalovirus CMV) as well as the human papilloma virus (HPV). Included in this article are the agents famciclovir, penciclovir, valganciclovir, imiquimod, docosanole and brivudin.

Original languageEnglish
Pages (from-to)313-321
Number of pages9
JournalIndian Journal of Pediatrics
Issue number4
StatePublished - Apr 2006


  • Herpes viruses
  • Systemic and topical antiviral agents
  • Viral infecting


Dive into the research topics of 'New antiviral agents'. Together they form a unique fingerprint.

Cite this